Goldman Sachs Aktienanleihe BAYN .../ DE000GG01ZG1 /
20/05/2024 10:09:41 | Diferencia+0.08 | Bid22:00:36 | Ask22:00:36 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
86.41EUR | +0.09% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
BAYER AG NA O.N. | 34.00 - | 26/06/2024 | Call |
GlobeNewswire
22:20
Kayne Anderson Energy Infrastructure Fund Completes Private Placement of $75 Million of Notes
GlobeNewswire
22:17
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integral Ad Scie...
GlobeNewswire
22:16
Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
GlobeNewswire
22:15
APA Announces over $700 Million in Asset Sales from Two Transactions for Non-core Texas Properties
GlobeNewswire
22:15
Gaming and Leisure Properties, Inc. Declares Second Quarter 2024 Cash Dividend of $0.76 Per Share
GlobeNewswire
22:14
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XPEL, Inc. - XPE...
GlobeNewswire
22:09
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against UnitedHealth Gr...
GlobeNewswire
22:07
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Intel Corporati...
GlobeNewswire
22:05
Zoom Video Communications Reports Financial Results for the First Quarter of Fiscal Year 2025
GlobeNewswire
22:05
VESTIS CORPORATION (NYSE: VSTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities C...
GlobeNewswire
22:05
Reliance Global Group Reports First Quarter 2024 Results and Provides Business Update
GlobeNewswire
22:05
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Frie...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página